Press Releases - 2024-09-23

Date	Title	Company
23-Sep-2024	Cenna Biosciences Receives NIH NIA Phase II SBIR Award for the Early Clinical Development of Nubytide TM, a First-in-Class, Disease-Modifying Peptide Drug for the Prevention and Treatment of Alzheimer’s Disease	AccessWire
23-Sep-2024	OrtoWay-US Inc. Announces Granting of U.S. Patent for OrtoWell(R) Distractor System for Spinal Surgery Corpectomy	AccessWire
23-Sep-2024	Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins	AccessWire
23-Sep-2024	Integrated DNA Technologies Unveils New Lymphoma Panel to Enhance Blood Cancer Research	Integrated DNA Technologies
23-Sep-2024	Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine	Vicebio Ltd
23-Sep-2024	Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old	Sanofi
23-Sep-2024	DARZALEX® (daratumumab)-based quadruplet regimen receives positive CHMP opinion for transplant-eligible patients with newly diagnosed multiple myeloma	Janssen-Cilag
23-Sep-2024	Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia	Teva Pharmaceutical Industries Ltd
23-Sep-2024	Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering	Zenas BioPharma
23-Sep-2024	Innovative Trials CEO named top Woman in Pharma at the Pharma Industry Awards UK	Innovative Trials
23-Sep-2024	Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant	Sanofi
23-Sep-2024	Biocomposites to showcase innovations in infection management at EBJIS 2024	Biocomposites
23-Sep-2024	Almirall to present new data on biologics for psoriasis and atopic dermatitis and celebrates 80 years of innovation at the EADV congress	Almirall
23-Sep-2024	Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia	Teva Pharmaceutical Industries Ltd
23-Sep-2024	Fasenra recommended for approval in the EU by CHMP for the treatment of eosinophilic granulomatosis with polyangiitis	AstraZeneca
23-Sep-2024	Mölnlycke Health Care partners with Ondine for Steriwave distribution collaboration in the key markets of the UK, Europe and the Middle East	Ondine Biomedical Inc
23-Sep-2024	2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA	Association of the British Pharmaceutical Industry (ABPI)
23-Sep-2024	Terumo Blood and Cell Technologies collaborates with Nova Biomedical to bring automated cell culture sensing to Quantum Flex	Terumo Blood and Cell Technologies
23-Sep-2024	European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement	The European Microbiome Innovation for Health
23-Sep-2024	Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer	Theriva™ Biologics, Inc.